prednisolone has been researched along with Hemangiosarcoma in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To develop effective therapies for angiosarcoma, we investigated the anti-tumor effects of etoposide (ETO), TNP-470 and prednisolone (PSL) using an established murine angiosarcoma cell line (ISOS-1)." | 7.70 | Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone. ( Fujimura, T; Hamada, Y; Haraguchi, F; Katsuoka, K; Ma, G; Masuzawa, M; Sakurai, Y; Tamauchi, H, 2000) |
| "To develop effective therapies for angiosarcoma, we investigated the anti-tumor effects of etoposide (ETO), TNP-470 and prednisolone (PSL) using an established murine angiosarcoma cell line (ISOS-1)." | 3.70 | Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone. ( Fujimura, T; Hamada, Y; Haraguchi, F; Katsuoka, K; Ma, G; Masuzawa, M; Sakurai, Y; Tamauchi, H, 2000) |
| "The principles of treatment for hemangiomas based upon our clinical classification are discussed and may be summarized as follows: 1." | 2.36 | Vascular and lymphatic tumors in infancy, childhood and adulthood: challenge of diagnosis and treatment. ( Edgerton, MT; Hiebert, JM, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, G | 1 |
| Masuzawa, M | 1 |
| Hamada, Y | 1 |
| Haraguchi, F | 1 |
| Tamauchi, H | 1 |
| Sakurai, Y | 1 |
| Fujimura, T | 1 |
| Katsuoka, K | 1 |
| Edgerton, MT | 1 |
| Hiebert, JM | 1 |
| Tamura, G | 1 |
| Kaizuka, H | 1 |
| Iwasaki, T | 1 |
| Satodate, R | 1 |
| Abe, H | 1 |
| Ishida, M | 1 |
| Mori, S | 1 |
1 review available for prednisolone and Hemangiosarcoma
| Article | Year |
|---|---|
Vascular and lymphatic tumors in infancy, childhood and adulthood: challenge of diagnosis and treatment.
Topics: Adult; Angiomatosis; Arteriovenous Malformations; Blood Coagulation Disorders; Child; Female; Gigant | 1978 |
2 other studies available for prednisolone and Hemangiosarcoma
| Article | Year |
|---|---|
Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic | 2000 |
[A case report of angiosarcoma of the breast].
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Hemangiosarcoma; Humans; L | 1987 |